179 related articles for article (PubMed ID: 26087178)
1. Is Development of a Vaccine against Cryptococcus neoformans Feasible?
Leopold Wager CM; Wormley FL
PLoS Pathog; 2015 Jun; 11(6):e1004843. PubMed ID: 26087178
[No Abstract] [Full Text] [Related]
2. Towards a vaccine for Cryptococcus neoformans: principles and caveats.
Datta K; Pirofski LA
FEMS Yeast Res; 2006 Jun; 6(4):525-36. PubMed ID: 16696648
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and prospects for a vaccine to prevent cryptococcosis.
Casadevall A; Pirofski LA
Med Mycol; 2005 Dec; 43(8):667-80. PubMed ID: 16422296
[TBL] [Abstract][Full Text] [Related]
4. Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.
Specht CA; Lee CK; Huang H; Tipper DJ; Shen ZT; Lodge JK; Leszyk J; Ostroff GR; Levitz SM
mBio; 2015 Dec; 6(6):e01905-15. PubMed ID: 26695631
[TBL] [Abstract][Full Text] [Related]
5. Innate host defenses against Cryptococcus neoformans.
Hole C; Wormley FL
J Microbiol; 2016 Mar; 54(3):202-11. PubMed ID: 26920880
[TBL] [Abstract][Full Text] [Related]
6. A Heat-Killed
Wang Y; Wang K; Masso-Silva JA; Rivera A; Xue C
mBio; 2019 Nov; 10(6):. PubMed ID: 31772051
[No Abstract] [Full Text] [Related]
7. A Call to Arms: Quest for a Cryptococcal Vaccine.
Caballero Van Dyke MC; Wormley FL
Trends Microbiol; 2018 May; 26(5):436-446. PubMed ID: 29103990
[TBL] [Abstract][Full Text] [Related]
8. Induction of Protective Immunity to Cryptococcal Infection in Mice by a Heat-Killed, Chitosan-Deficient Strain of Cryptococcus neoformans.
Upadhya R; Lam WC; Maybruck B; Specht CA; Levitz SM; Lodge JK
mBio; 2016 May; 7(3):. PubMed ID: 27165801
[TBL] [Abstract][Full Text] [Related]
9. Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.
Zhai B; Wozniak KL; Masso-Silva J; Upadhyay S; Hole C; Rivera A; Wormley FL; Lin X
mBio; 2015 Oct; 6(5):e01433-15. PubMed ID: 26443458
[TBL] [Abstract][Full Text] [Related]
10. Vaccine Strategies for Cryptococcus neoformans.
Brauer VS; Querobino SM; Matos GS; Dasilva D; Del Poeta M
Methods Mol Biol; 2024; 2775():411-422. PubMed ID: 38758334
[TBL] [Abstract][Full Text] [Related]
11. Immunization of mice with an avirulent pseudohyphal form of Cryptococcus neoformans.
Fromtling RA; Blackstock R; Hall NK; Bulmer GS
Mycopathologia; 1979 Sep; 68(3):179-81. PubMed ID: 394001
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis.
Chow SK; Casadevall A
Vaccine; 2011 Feb; 29(10):1891-8. PubMed ID: 21238568
[TBL] [Abstract][Full Text] [Related]
13. Design of a cryptococcus neoformans vaccine by subtractive proteomics combined with immunoinformatics.
Zhu F; Zhou Z; Ma S; Xu Y; Tan C; Yang H; Zhang P; Qin R; Luo Y; Pan P; Chen J
Int Immunopharmacol; 2024 Jun; 135():112242. PubMed ID: 38772296
[TBL] [Abstract][Full Text] [Related]
14. Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans.
Anderson DM; Dykstra MA
Mycopathologia; 1984 Jun; 86(3):169-77. PubMed ID: 6382015
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responses.
Chaturvedi AK; Weintraub ST; Lopez-Ribot JL; Wormley FL
Proteomics; 2013 Dec; 13(23-24):3429-41. PubMed ID: 24170628
[TBL] [Abstract][Full Text] [Related]
16. Polysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens.
Pirofski LA
Trends Microbiol; 2001 Sep; 9(9):445-51. PubMed ID: 11553457
[TBL] [Abstract][Full Text] [Related]
17. Epitope-Based Immunoinformatic Approach on Heat Shock 70 kDa Protein Complex of
Elhassan RM; Alsony NM; Othman KM; Izz-Aldin DT; Alhaj TA; Ali AA; Abashir LA; Ahmed OH; Hassan MA
J Immunol Res; 2021; 2021():9921620. PubMed ID: 34471644
[TBL] [Abstract][Full Text] [Related]
18. Methodology for Anti-Cryptococcal Vaccine Development.
Chaturvedi AK; Wormley FL
Methods Mol Biol; 2017; 1625():129-140. PubMed ID: 28584988
[TBL] [Abstract][Full Text] [Related]
19. Purification and characterization of a second immunoreactive mannoprotein from Cryptococcus neoformans that stimulates T-Cell responses.
Huang C; Nong SH; Mansour MK; Specht CA; Levitz SM
Infect Immun; 2002 Oct; 70(10):5485-93. PubMed ID: 12228274
[TBL] [Abstract][Full Text] [Related]
20. Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens.
Hester MM; Lee CK; Abraham A; Khoshkenar P; Ostroff GR; Levitz SM; Specht CA
Vaccine; 2020 Jan; 38(3):620-626. PubMed ID: 31699504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
